NervGen Pharma Corp. Common stock
USD1.98
+0.07 (+3.66%)
CEO
Adam H. Rogers
IPO Date
2021-02-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$1.93
Prev. Close
$1.91
Day Low
$1.92
Day High
$1.99
52W Low
$1.87
52W High
$6.30
Market Cap
$0.16B
Volume
0.21M
| 59,524 |
| $0.00 |
| 23 Apr 2008 | BIRNDORF HOWARD C | director, officer: Executive Chairman and CEO | A-Award | Acquired | 547,500 | $0.42 |
| 15 Jun 2007 | SCHREIBER DAVID | director | A-Award | Acquired | 18,116 | $0.00 |
| 15 Jun 2007 | BIRNDORF HOWARD C | director, officer: Executive Chairman and CEO | A-Award | Acquired | 547,500 | $1.39 |
| 15 Jun 2007 | Dreismann Heiner | director | A-Award | Acquired | 18,116 | $0.00 |
| 14 Dec 2006 | BIRNDORF HOWARD C | director, officer: Executive Chairman and CEO | A-Award | Acquired | 100,000 | $2.09 |
| 14 Dec 2006 | BIRNDORF HOWARD C | director, officer: Executive Chairman and CEO | A-Award | Acquired | 280,000 | $2.09 |
| 2 Nov 2006 | Dreismann Heiner | director | A-Award | Acquired | 25,000 | $1.95 |
| 2 Nov 2006 | Dreismann Heiner | director | A-Award | Acquired | 8,113 | $0.00 |